The multifaceted role of SOX2 in breast and lung cancer dynamics
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2024.155386 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Kiavash Hushmandi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, the Islamic Republic of Ira…. Hauptthemen laut MEDLINE: SOXB1 Transcription Factors, Lung Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 202 Literaturangaben.
Abstract (Originalsprache)
Breast and lung cancers are leading causes of death among patients, with their global mortality and morbidity rates increasing. Conventional treatments often prove inadequate due to resistance development. The alteration of molecular interactions may accelerate cancer progression and treatment resistance. SOX2, known for its abnormal expression in various human cancers, can either accelerate or impede cancer progression. This review focuses on examining the role of SOX2 in breast and lung cancer development. An imbalance in SOX2 expression can promote the growth and dissemination of these cancers. SOX2 can also block programmed cell death, affecting autophagy and other cell death mechanisms. It plays a significant role in cancer metastasis, mainly by regulating the epithelial-to-mesenchymal transition (EMT). Additionally, an imbalanced SOX2 expression can cause resistance to chemotherapy and radiation therapy in these cancers. Genetic and epigenetic factors may affect SOX2 levels. Pharmacologically targeting SOX2 could improve the effectiveness of breast and lung cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, the Islamic Republic of Iran. Electronic address: houshmandi.kia7@ut.ac.ir.
- Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, the Islamic Republic of Iran.
- Campus Venlo, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, The Netherlands.
- Department of Public Health,School of Health,Jiroft University of Medical Sciences,Jiroft, the Islamic Republic of Iran.
- Department of Translational Sciences, Xsphera Biosciences Inc. Boston, MA, USA; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Department of Urologic Sciences and Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, V6H3Z6 Canada.
Zitieren
APA
Hushmandi, K., Saadat, S. H., Mirilavasani, S., Daneshi, S., Aref, A. R., Nabavi, N., Raesi, R., Taheriazam, A., & Hashemi, M. (2024). The multifaceted role of SOX2 in breast and lung cancer dynamics. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155386
Vancouver
Hushmandi K, Saadat SH, Mirilavasani S, Daneshi S, Aref AR, Nabavi N, et al. The multifaceted role of SOX2 in breast and lung cancer dynamics. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155386
BibTeX
@article{Hushmandi2024,
author = {Hushmandi, Kiavash and Saadat, Seyed Hassan and Mirilavasani, Seyedalireza and Daneshi, Salman and Aref, Amir Reza and Nabavi, Noushin and Raesi, Rasoul and Taheriazam, Afshin and Hashemi, Mehrdad},
title = {The multifaceted role of SOX2 in breast and lung cancer dynamics},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2024.155386}
}
EUVIMED